Patents for A61P 33 - Antiparasitic agents (21,787) |
---|
08/24/2011 | EP2360184A2 Antibodies that bind human interleukin-18 and methods of making and using |
08/24/2011 | EP2358687A1 Thioamide compounds, method of making and method of using thereof |
08/24/2011 | CN201939730U 治疗酒糟鼻的凝胶鼻贴 Rosacea treatment gel bitie |
08/24/2011 | CN102164920A Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
08/24/2011 | CN102164912A Process for making quinolone compounds |
08/24/2011 | CN102164605A Inhibitors of the plasmodial surface anion channel as antimalarials |
08/24/2011 | CN101506166B Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds |
08/23/2011 | US8003347 Nucleic acids encoding ChemerinR ligands |
08/23/2011 | CA2451006C 1,2,4-trioxolane antimalarials |
08/18/2011 | WO2011098408A2 Hydrazine-substituted anthranilic acid derivatives |
08/18/2011 | WO2011044230A9 N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions |
08/18/2011 | US20110201687 Amide derivative, pest control agent containing the amide derivative, and use of the amide derivative |
08/18/2011 | US20110201550 Combination of amidine derivatives with cyclic depsipeptides |
08/18/2011 | US20110200657 Methods of using nanoemulsion compositions having anti-inflammatory activity |
08/17/2011 | EP2357200A1 Human antibodies that bind human TNFalpha |
08/17/2011 | EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
08/17/2011 | EP2357008A1 Albumin fusion proteins |
08/17/2011 | EP2356093A1 Carbazole compounds and therapeutic uses of the compounds |
08/17/2011 | EP2355831A1 Use of inkt or tlr agonists for protecting against or treating a disease such as acute infection or cancer |
08/17/2011 | EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS |
08/17/2011 | CN201930267U 新型蜂药挂片 The new drug coupon bee |
08/17/2011 | CN1549717B Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses |
08/17/2011 | CN102151263A Veterinary compound hydrochloric acid injection and preparation method thereof |
08/17/2011 | CN102151261A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
08/17/2011 | CN101579309B Anti-parasitic ivermectin transdermal solution used for livestock and preparation method thereof |
08/17/2011 | CN101336991B Medicine for treating gynaecologic pruritus vulvae and colpitis |
08/17/2011 | CN101139369B Method for preparing Xanthoceras sorbifolia husk total saponin extractive |
08/16/2011 | CA2405450C Dermacentor variabilis gaba-gated chloride channels |
08/11/2011 | WO2011095939A1 Antimicrobial peptides of the cecropin family and therapeutic uses thereof |
08/11/2011 | WO2011095581A1 S piroindoline compounds for use as anthelminthi cs |
08/11/2011 | US20110196027 Beta-lactones as antibacterial agents |
08/11/2011 | US20110196011 Substituted arylpyrazoles |
08/11/2011 | US20110195944 Modified release emulsions for application to skin or vaginal mucosa |
08/11/2011 | US20110195094 Triazole compounds that modulate hsp90 activity |
08/11/2011 | US20110195089 Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens |
08/11/2011 | US20110195073 Compositions and methods for stimulating an immune response |
08/11/2011 | US20110195047 Oncostatin m as promoter of immunostimulatory activity of human epithelial cells |
08/10/2011 | EP2352723A2 Halogen-substituted compounds used as pesticides |
08/10/2011 | EP2352520A1 Vaccination with poxvirus vectors via mechanical epidermal disruption |
08/10/2011 | CN101700227B Matrine colon targeted adhesive pellet and preparation method thereof |
08/10/2011 | CN101590199B Chinese medicinal decoction for treating trichomonal vaginitis |
08/10/2011 | CN101574430B Chinese medicinal composition for resisting trichomonas columbae disease and method for preparing oral liquid thereof |
08/10/2011 | CN101474181B Application of corytuberine in preparing medicament for resisting Eimeria tenella |
08/10/2011 | CN101209043B Application of sanguinarine or toddaline in prevention and cure of schistosomiasis |
08/09/2011 | US7994318 Coumarin derivatives useful as TNFα inhibitors |
08/09/2011 | US7994201 Anthranilamide compounds, process for their production and pesticides containing them |
08/04/2011 | WO2011094628A1 Compositions and methods for treating toxoplasmosis. cryptosporidiosis and other apicomplexan protozoan related diseases |
08/04/2011 | WO2011093415A1 Composition for control of animal parasites, and method for control of animal parasites |
08/04/2011 | WO2011073630A3 Parasite vaccine |
08/04/2011 | WO2011041304A3 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase |
08/04/2011 | US20110190399 Curcumin nanoparticles and methods of producing the same |
08/04/2011 | US20110190338 Compounds and Compositions Useful in the Treatment of Malaria |
08/04/2011 | US20110190325 Compounds, their syntheses, and thier uses |
08/04/2011 | US20110190239 Bmi-1 protein expression modulators |
08/04/2011 | US20110190235 Boron-containing small molecules as antiprotozoal agents |
08/04/2011 | US20110190233 Anionic conjugates of glycosylated bacterial metabolite |
08/04/2011 | US20110189321 Medicinal agent exhibiting antiprotozoal activity to trichomonas vaginalis in an in-vitro model system |
08/04/2011 | US20110189239 Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same |
08/04/2011 | US20110189218 Plasmodium vivax hybrid circumsporozoite protein and vaccine |
08/04/2011 | US20110189156 Method for Treating Systemic Bacterial, Fungal and Protozoan Infection |
08/04/2011 | CA2786802A1 Composition for exterminating animal parasite comprising an aromatic carboxamide derivative and method thereof |
08/03/2011 | EP2349334A1 S1p receptor agonists for the treatement of cerebral malaria |
08/03/2011 | EP1317282B1 Vectors for molecule delivery to cd11b expressing cells |
08/03/2011 | CN102139098A Lysozyme-rich novel biological synergist |
08/03/2011 | CN102138934A Emulsifiable paste for treating scabies |
08/03/2011 | CN102138890A Praziquantel transdermal preparation and applications thereof |
08/03/2011 | CN101591285B Propionamides compound and usage thereof |
08/02/2011 | CA2505067C Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
08/02/2011 | CA2488242C Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
08/02/2011 | CA2442682C Monocyte-specific particulate delivery vehicle |
08/02/2011 | CA2434063C Substituted quinolines for the treatment of protozoan and retrovirus co-infections |
07/28/2011 | WO2011091122A1 Methods for internally controlling or treating equine bot larvae |
07/28/2011 | WO2011089225A1 Use of aprotinin for treating parasitic infections and prognosing bovine trypanotolerance |
07/28/2011 | US20110184046 Compositions And Methods For Inhibiting Expression Of GSK-3 Genes |
07/28/2011 | US20110184034 Severe sepsis preventive therapeutic agent |
07/28/2011 | US20110183997 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
07/28/2011 | US20110183937 Agent for Combating Ectoparasites |
07/28/2011 | US20110182933 Modified vaccinia ankara virus variant |
07/28/2011 | US20110182929 Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia |
07/28/2011 | US20110182847 Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimens |
07/28/2011 | CA2787078A1 Methods for internally controlling or treating equine bot larvae |
07/27/2011 | EP2346855A2 Process for making quinolone compounds |
07/27/2011 | EP2346502A1 Derivatives of hypoestoxides for the treatment of malaria |
07/27/2011 | EP1267891B1 Antiadhesive carbohydrates |
07/27/2011 | CN102137854A 4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases |
07/27/2011 | CN102133245A Brucea javanica oil obtained by reducing content of protein, and medicine composite and preparation method thereof |
07/27/2011 | CN102133173A Moxidectin pour sprinkling preparation and preparation method thereof |
07/27/2011 | CN101632743B Method for extracting limonin substances |
07/27/2011 | CN101538254B Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and therapeutic use |
07/27/2011 | CN101371831B Use of Fructus arctii aglycone in medicament for killing ectoparasite of aquatic animal |
07/27/2011 | CN101367876B Monoclonal antiidiotypic antibody NP30 single-specificity double-chain antibody of Japanese blood fluke, preparation method and uses thereof |
07/27/2011 | CN101361791B Detoxification medicine composition |
07/27/2011 | CN101322746B Secondary fermentation method natural medicinal preparation, preparation and use |
07/27/2011 | CN101062167B Preparing method of Chinese medicine composition for treating gynecopathy |
07/26/2011 | US7985591 Dirofilaria cuticle protein for use in identifying modulators and preparing vaccines for prevention and treatment worm infection |
07/26/2011 | CA2508412C Pesticidal 5-(acylamino) pyrazole derivatives |
07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
07/26/2011 | CA2222757C Modified/chimeric superantigens and their use |
07/21/2011 | WO2011086531A2 New anti-malarial agents |
07/21/2011 | WO2011085720A1 Biologically active molecules for influencing virus-, bacteria-, parasite-infected cells and/or tumor cells and method for the use thereof |